Estonia is taking substantial steps with its smart and innovative solutions in all fields involving medicine and medical equipment. It would be rather ill of us to not share our success with the world.
Hence, Enterprise Estonia will be taking 10 Estonian companies to the the largest event for the medical industry worldwide – MEDICA.
It’ll all happen on 14–17 November in Düsseldorf, Germany.
Come meet us at the fair, stand 15F18.
Solis BioDyne is a global biotech company based in Estonia and a world leader in the development of room-temperature stable reagents and enzymes. With over 27 years of experience in industrial-scale protein design and production, we offer flexibility and time-to-market leverage to create customized products and solutions, ranging from technical support to assay optimization. Our high standards have established Solis BioDyne as a trusted trademark worldwide, serving customers in over 110 countries.
Goodpoint Chemicals started business in 2009. We design, develope and produce high-quality and user-friendly products for medical and veterinary institutions with a wide efficacy spectrum, that have been tested in accredited laboratories. We listen carefully to our clients throughout product development and take account their input and wishes. Over 15 of our products are CE-certified. We are proud of our long-time partnerships with companies such as Lonza Corporation, BASF Corporation Chemicals Division, Brill&Partner GmBH, Robert Koch Institute, Eurofins and University of Bonn. Our latest products are the wound irrigaton solution Globasept®Wound Sol. and highly demanded chlorhexidine-based disinfectants.
Nanordica Medical has developed an Advanced Wound Dressing that prevents wound infection and promotes wound healing. Nanordica Medical has demonstrated that the wound dressing removes bacterial infection 8x better than the current best. Our value propositions are high efficacy and low cost. Our business model is B2B using distributors to reach our customers in hospitals, outpatient clinics, and pharmacies. Nanordica Medical has a priority for intellectual property and has completed a pilot clinical trial at the largest Estonian hospital. The data from clinical trial showed wound closure 2 times faster than the market leader. Our mission is to bring the product to the market to improve the outcome of wound infections, lower healthcare costs, and help hundreds of millions of patients. Nanordica Medical is open for co-development projects and commercial partnerships in veterinary medicine.
MERIANTO (est. 2004) IS A DESIGNER AND MANUFACTURER OF SPECIAL PURPOSE (INCL. HOSPITAL) FURNITURE WITH MANY YEARS OF EXPERIENCE.
Since its inception, Merianto Medical has the intention of providing interior solutions to healthcare institutions – considering their high standards and special needs. Merianto’s widespread experience with special solutions and quality client relationships support Merianto Medical’s creation of truly contemporary hospital solutions. Long-term experience in specialty furniture and the creation of complex interior solutions aid in creating a unique and complete solution for the client’s hospital environment.
OUR PARTNERS INCLUDE ALMOST ALL LARGEST HOSPITALS IN FINLAND AND ESTONIA, MAJOR CONSTRUCTION COMPANIES, HEALTH CENTERS, ELDERLY HOMES.
Migrevention is a an Estonian health technology company and Estonia’s first software based medical device manufacturer. Migrevention is a fully digital headache clinic and we offer digital solutions for patients, specialists and clinics to monitor, diagnose and treat migraine and other primary headaches. Migrevention’s mission is raising awareness and providing more accessible treatment to over 1.4B migraine patients in the world through digital therapeutics. At the moment, only 1-4% of migraine patients get evidence-based treatment, and the vast majority stays undiagnosed and untreated. Without sufficient treatment, the medical costs add up to 155 billion € per year only in the EU; and risks for migraine chronification, secondary health problems, and medication overuse headache rise drastically.
14 Nov 2022
Düsseldorf, Germany